An Open-label Extended Clinical Protocol of Ranibizumab to Evaluate Safety and Efficacy in Rare VEGF Driven Ocular Diseases.
Clinical trial NCT01908816 · COMPLETED
Trial details
- NCT number
- NCT01908816
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-09-26
- Primary completion
- 2016-01-08
- Enrollment
- 270
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.